Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C3EQ | ISIN: US69404D1081 | Ticker-Symbol: P09
Tradegate
06.06.25 | 17:26
0,962 Euro
+9,50 % +0,084
1-Jahres-Chart
PACIFIC BIOSCIENCES OF CALIFORNIA INC Chart 1 Jahr
5-Tage-Chart
PACIFIC BIOSCIENCES OF CALIFORNIA INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9570,98218:04
0,9570,98218:04

Aktuelle News zur PACIFIC BIOSCIENCES OF CALIFORNIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoHere's Why You Should Add PacBio Stock to Your Portfolio Now14
DoPacific Biosciences auf der Jefferies-Konferenz: Rekordumsatz und strategische Neuausrichtung20
23.05.PacBio Stock Slips Despite New China Distribution Deal With Haorui19
22.05.PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene19
PACIFIC BIOSCIENCES OF CALIFORNIA Aktie jetzt für 0€ handeln
15.05.Where Pacific Biosciences Stands With Analysts53
12.05.PACB Stock May Rise Following the Deal With Chulalongkorn University22
12.05.PacBio clears allegations after special investigation25
12.05.PacBio Board Independent Investigation Concludes Allegations Unsubstantiated188MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the "Special Committee") has concluded its independent...
► Artikel lesen
09.05.PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates31
09.05.Pacbio adjusts 2025 revenue guidance to $150M-$170M amid macroeconomic challenges30
08.05.PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - 8-K, Current Report5
08.05.PacBio Announces First Quarter 2025 Financial Results488MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025Q1 2024Revenue$37.2...
► Artikel lesen
06.05.Cathie Wood's ARK ETF adjusts positions in PACB, PLTR, and more104
05.05.First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand7
28.04.PacBio to enhance DNA methylation detection technology18
28.04.PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry9
22.04.PacBio, Davos Alzheimers Collaborative Join For North African Dementia Registry Project375WASHINGTON (dpa-AFX) - The Davos Alzheimers Collaborative, a global initiative to prevent Alzheimers disease and improve brain health, announced that PacBio (PACB) will be a technology partner...
► Artikel lesen
22.04.PacBio partners with global Alzheimer's initiative8
22.04.Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa911MENLO PARK, Calif. and GENEVA, Switzerland, April 22, 2025 (GLOBE NEWSWIRE) -- The Davos Alzheimer's Collaborative (DAC), a global initiative to prevent Alzheimer's disease and improve brain health...
► Artikel lesen
10.04.Canaccord maintains $3 price target on PACB, reiterates Buy22
Weiter >>
84 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,10